FDA Green-Lights Selling of 23andMe's First-Ever Home Genetic Testing Kit

The U.S. Food and Drug Administration (FDA) announced on Thursday that it will allow the marketing of 23andMe Personal Genome Service Genetic Health Risk (GHR) tests to give consumers information regarding their risk to certain diseases.